A&O Shearman
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
A&O Shearman fields a highly experienced healthcare and life sciences team with a strong record across both contentious and non-contentious mandates. Drawing on deep industry insight, the practice advises clients in the biotech, medtech and pharmaceutical sectors on high-stakes patent work, commercial collaborations, regulatory challenges and growth-stage transactions. Leadership of the practice is shared by Frits Gerritzen, whose IP litigation expertise spans complex disputes involving pharma products, antibodies and medical technologies, and Christiaan de Brauw, a corporate specialist who frequently represents biotech companies and venture capital funds in M&A and investment mandates. The ‘very effective’ Jort de Groodt plays a central role in the team’s life sciences and technology offering.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Knowledge of our company. Strategic thinking around how to approach a funding round or other event.'
‘Jort de Groodt has been very effective with his team to deliver the results we wanted.'
Key clients
- Logex
- Protix
Work highlights
Advised Logex International Healthcare Analytics B.V - Thoma Bravo on its acquisition of LOGEX.